LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
Meiyan Luo,1– 3 Qian Zhang,1– 3 Yingchun Hu,4 Changfeng Sun,1– 3 Yunjian Sheng,1– 3 Cunliang Deng1– 3 1Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Louzhou, 646000, People’s Republic of China; 2Department of Tuberculosis, The Affiliated Hospital of Sout...
Main Authors: | Luo M, Zhang Q, Hu Y, Sun C, Sheng Y, Deng C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/lgals3bp-a-potential-plasma-biomarker-associated-with-diagnosis-and-pr-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma
by: Xia He, et al.
Published: (2019-05-01) -
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
by: Emily Capone, et al.
Published: (2020-10-01) -
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
by: Wenjing Wu, et al.
Published: (2019-06-01) -
Mice lacking galectin-3 (Lgals3) function have decreased home cage movement
by: Tammy R. Chaudoin, et al.
Published: (2018-05-01) -
LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages
by: Wan-Ming Hu, et al.
Published: (2020-05-01)